Reversing chemotherapy resistance in pancreatic cancer retrieved 4 July 2024 from https://medicalxpress.com/news/2024-07-reversing-chemotherapy-resistance-pancreatic-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.19 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Different outcomes for positive, negative pancreatic cancer patients receiving chemoradiation and systemic therapyNRG Oncology recently reported the results from the radiotherapy randomization, which was the second step of their NRG-RTOG 0848 clinical study comparing adjuvant chemotherapy with or without chemoradiation for patients with resected periampullary pancreatic adenocarcinoma.
Source: medical_xpress - 🏆 101. / 51 Read more »
Team reports on synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cellsA new research paper titled 'Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy' has been published in Oncotarget.
Source: medical_xpress - 🏆 101. / 51 Read more »
Breaking down barriers: ROCK2 inhibition facilitates drug delivery in fibrotic pancreatic cancerPancreatic cancer, recognized as one of the deadliest cancers, poses a persistent challenge for medical professionals globally due to its aggressive behavior and resistance to conventional therapies.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers detail molecular pathway that impacts pancreatic cancer progression and treatment responseResearchers at UNC Lineberger Comprehensive Cancer Center and colleagues have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene or 'oncogene,' and how its activities impact pancreatic cancer outcomes.
Source: medical_xpress - 🏆 101. / 51 Read more »
Discovery may explain pancreatic cancer's cellular amnesiaThings aren't always as they seem. Take pancreatic cancer, for example. In up to one in 10 cases, researchers have documented a peculiar characteristic. Some of the pancreatic cells appear to have lost their identity. It's as if they forget what they are.
Source: medical_xpress - 🏆 101. / 51 Read more »
CSHL researchers reveal MED12 as key player in basal-like pancreatic cancerThings aren't always as they seem. Take pancreatic cancer, for example. In up to one in 10 cases, researchers have documented a peculiar characteristic.
Source: NewsMedical - 🏆 19. / 71 Read more »